RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Terlipressin and Albumin Combination Therapy Improves Renal Function in HRS-1
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 48
SP 17
OP 18
DO 10.1177/155989771448012
UL http://mdc.sagepub.com/content/14/48/17.2.abstract
AB This article presents initial data from A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin [REVERSE; NCT01143246], the largest trial to date in type 1 hepatorenal syndrome using terlipressin.